Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

VA tests Mind-Body exercise to keep dementia patients moving

NCT ID NCT06972004

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a special exercise program for older Veterans with dementia living in VA nursing homes. The program, called PLIÉ, combines gentle movement and mental focus to improve physical function, mood, and social engagement. Staff will be trained to lead the classes, and researchers will measure changes in residents' abilities over 12 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 288 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: CLC internal facilitators/champions Inclusion criteria: * Full-time CLC clinical staff member (including registered nurses, certified nursing assistants, nurse aids, recreation therapists, occupational therapists, physical therapists, mental health professionals or others) * Willingness to facilitate PLIÉ-CLC implementation at their site * Willingness to participate in initial and debrief site visit PLIÉ-CLC staff instructors Inclusion criteria: * CLC clinical staff member or volunteer interested in learning to lead PLIÉ-CLC classes * Willingness to participate in remote training process * Willingness to lead PLIÉ classes locally, including tracking attendance and other process measures * Willingness to participate in initial and debrief site visits and biweekly check-ins Veteran residents of Community Living Centers (CLCs) Inclusion criteria: * Long-stay resident (have resided at the facility for at least 45 days and are not expected to be discharged during the study period) * Not planning to be discharged within the next 12 months * Not receiving hospice care. * Cognitive impairment * Ability to sit in a standard chair or wheelchair unaided for a 1-hour class * English language fluency CLC directors Inclusion criteria: * Recommended by VHA leader as likely to be 'early adopter' based on successful implementation of program such as STAR-VA OR * g based on patient population (primarily palliative care or long stay maintenance/custodial care Exclusion Criteria: CLC internal facilitators/champions exclusion Criteria: \- Planning to leave the facility in next 12 months PLIÉ-CLC staff instructors exclusion criteria: \- Planning to leave the facility in next 12 months Veteran residents of Community Living Centers (CLCs) exclusion Criteria: * Comatose * Bedbound * Severe hearing, visual or communication challenges (i.e., unable to hear, see or understand well enough to participate) * Limited life expectancy (e.g., eligible for hospice) * Lack of ability to consent/assent to study procedures CLC Directors exclusion criteria: \- Lack of willingness or interest in participating

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive dysfunction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior cognitive disorder Cognitive Dysfunction dementia Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • San Francisco VA Medical Center, San Francisco, CA

    San Francisco, California, 94121-1563, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.